335 related articles for article (PubMed ID: 15719701)
1. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications.
Brossard JH; Yamamoto LN; D'Amour P
Semin Dial; 2002; 15(3):196-201. PubMed ID: 12100458
[TBL] [Abstract][Full Text] [Related]
3. Circulating PTH molecular forms: what we know and what we don't.
D'Amour P
Kidney Int Suppl; 2006 Jul; (102):S29-33. PubMed ID: 16810307
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.
D'Amour P; Brossard JH; Räkel A; Rousseau L; Albert C; Cantor T
Clin Chem; 2005 Jan; 51(1):169-76. PubMed ID: 15514090
[TBL] [Abstract][Full Text] [Related]
5. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.
Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; D'Amour P
Endocrinology; 2001 Apr; 142(4):1386-92. PubMed ID: 11250917
[TBL] [Abstract][Full Text] [Related]
6. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.
Divieti P; John MR; Jüppner H; Bringhurst FR
Endocrinology; 2002 Jan; 143(1):171-6. PubMed ID: 11751606
[TBL] [Abstract][Full Text] [Related]
7. Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays.
D'Amour P; Räkel A; Brossard JH; Rousseau L; Albert C; Cantor T
J Clin Endocrinol Metab; 2006 Jan; 91(1):283-9. PubMed ID: 16219713
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H
Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone: new assays, new receptors.
Martin KJ; Akhtar I; González EA
Semin Nephrol; 2004 Jan; 24(1):3-9. PubMed ID: 14730504
[TBL] [Abstract][Full Text] [Related]
11. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.
D'Amour P; Brossard JH; Rousseau L; Nguyen-Yamamoto L; Nassif E; Lazure C; Gauthier D; Lavigne JR; Zahradnik RJ
Kidney Int; 2005 Sep; 68(3):998-1007. PubMed ID: 16105030
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism for skeletal resistance in uremia.
Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic regulation of circulating PTH: significance in health and in disease.
D'Amour P
Clin Biochem; 2012 Aug; 45(12):964-9. PubMed ID: 22569597
[TBL] [Abstract][Full Text] [Related]
14. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.
Lewin E; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551
[TBL] [Abstract][Full Text] [Related]
15. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
16. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
Hackeng WH; Lips P; Netelenbos JC; Lips CJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):447-53. PubMed ID: 3088025
[TBL] [Abstract][Full Text] [Related]
18. Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology.
D'Amour P; Brossard JH
Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):330-6. PubMed ID: 15931000
[TBL] [Abstract][Full Text] [Related]
19. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
Goodman WG
Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
[TBL] [Abstract][Full Text] [Related]
20. Critical issues of PTH assays in CKD.
Komaba H; Goto S; Fukagawa M
Bone; 2009 Apr; 44(4):666-70. PubMed ID: 19159701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
